Cargando…
An Immuno-Clinic score model for evaluating T cell immunity and predicting early antiviral therapy effectiveness in chronic hepatitis B
We generated an Immuno-Clinic score (ICS) model to evaluate T cell immunity based on the clustering of antiviral cytokines and inhibitory molecules in 229 naïve chronic hepatitis B (CHB) patients. 126 patients receiving antiviral therapy were used to validate the model for predicting antiviral thera...
Autores principales: | Gu, Yurong, Li, Xiaoyan, Gu, Lin, Lian, Yifan, Wang, Ke, Chen, Youming, Lai, Jing, Mei, Yongyu, Liu, Jing, Huang, Zexuan, Zhang, Min, Chen, Lubiao, Huang, Yuehua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7803537/ https://www.ncbi.nlm.nih.gov/pubmed/33401245 http://dx.doi.org/10.18632/aging.202274 |
Ejemplares similares
-
Veritable antiviral capacity of natural killer cells in chronic HBV infection: an argument for an earlier anti-virus treatment
por: Li, Xiaoyan, et al.
Publicado: (2017) -
Association among cytokine profiles of innate and adaptive immune responses and clinical-virological features in untreated patients with chronic hepatitis B
por: Gu, Yurong, et al.
Publicado: (2020) -
Serum HBV pregenomic RNA is correlated with Th1/Th2 immunity in treatment‐naïve chronic hepatitis B patients
por: Gu, Yurong, et al.
Publicado: (2019) -
Correlations between cytokines produced by T cells and clinical-virological characteristics in untreated chronic hepatitis B patients
por: Gu, Yurong, et al.
Publicado: (2019) -
Serum HBV pregenomic RNA exhibited opposite associations with NK(dim) and NK(bright) cell immunity in treatment-naïve chronic hepatitis B patients
por: Gu, Yurong, et al.
Publicado: (2021)